Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel | Issue: May 2012 | May 8, 2012

Page: 1 2 3 4 5 6 | Single Page

Share:

Filed under:Axial Spondyloarthritis Conditions Profiles Research Rheum Rheumatoid Arthritis Tagged with:Ankylosing Spondylitis Biologics Career drug Profile radiograph Research Training

Related Articles

To Measure is to Know

October 1, 2007

Piet van Riel, MD, PhD, shepherd of RA improvement criteria

Target Remission

March 1, 2007

Strategies to identify and track remission in your RA patients

“A Common Language for Spondyloarthritis”

December 1, 2010

ASAS fills a niche, changes dogma with consensus approach

ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease

December 1, 2012

More finely tuned view of ankylosing spondylitis leads to better treatment, expert says

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences